CV Lattes
ResearcherID
ORCID
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
I graduated in Physical Education at the University of Sao Paulo (1984) and MA (1992) and Ph.D (1999) also at the University of Sao Paulo. Currently is Professor in the School of Physical Education and Sport at the University of Sao Paulo and mentor of the Postgraduate Course. My interest is in the Cardiovascular Exercise Physiology area , investigating mainly on the following topics: Exercise in cardiovascular disease and Neurovascular control in cardiovascular diseases. Is CNPq Researcher. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Despite of the uninterrupted development of new medications for the treatment of cancer, the survival rate continues low especially in those patients in the advanced stage of the disease. Recent observations show that new therapeutics increase the susceptibility for cardiovascular diseases, which turns out to be the treatment of cancer even more complex. Cardiac dysfunction due to cardiot…
Accumulated evidences show that exercise training plays an important role in cardiovascular disease. The present study will focus on the effects that exercise training may have on muscle mechanoreflex and metaboreflex controls of sympathetic nerve activity in patients with heart failure. In addition, we will investigate the cellular mechanisms involved in these controls. At a vascular lev…
According to the World Health Organization (WHO), Cardiovascular Disease (CVD) is the leading cause of Death among Chronic Noncommunicable Diseases (DCNT) with 17.7 million global deaths in 2015, which represents 45% of all DCNT deaths. Among CVD, Coronary Artery Disease (CAD) has a high prevalence. The pathophysiology of CAD mainly involves a complex inflammatory atherosclerotic process,…
Heart failure (HF) is a complex syndrome, considered as the leading cause of hospitalization in patients over the age of 60 years, and accounts for about 30 to 40% of mortality in patients with severe HF. It is also known that the neurohumoral excitation is a hallmark of HF and independent predictor of mortality in patients suffering from this syndrome. The sympathetic nervous system infl…
The prevalence of type 2 diabetes (T2D) is increasing by alarming proportions in the US and worldwide. Over the last two decades, the number of new cases of diabetes has almost tripled in the US and current projections estimate that one in three Americans will have diabetes by 2050. The effects of vascular insulin resistance are particularly important at the level of resistance arteries, …
Heart failure (HF) is the first cause of mortality in aged people and it is estimated that prevalence of HF is 8.4% for people aged 75 years or older. The most recent epidemiological studies suggest that the prevalence and hospitalizations related to HF with preserved ejection fraction (HFpEF) is rising, and the growing elderly population guarantees further worsening of these trends. To d…
| 5 / 3 | Completed research grants |
| 3 / 2 | Completed scholarships in Brazil |
| 2 / 2 | Completed scholarships abroad |
| 10 / 7 | All research grants and scholarships |
| Associated processes | |